291 related articles for article (PubMed ID: 26551597)
1. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
[TBL] [Abstract][Full Text] [Related]
2. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
[TBL] [Abstract][Full Text] [Related]
3. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
4. CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration
Vanheule V; Boff D; Mortier A; Janssens R; Petri B; Kolaczkowska E; Kubes P; Berghmans N; Struyf S; Kungl AJ; Teixeira MM; Amaral FA; Proost P
Front Immunol; 2017; 8():530. PubMed ID: 28539925
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
Vanheule V; Crijns H; Poosti F; Ruytinx P; Berghmans N; Gerlza T; Ronsse I; Pörtner N; Matthys P; Kungl AJ; Opdenakker G; Struyf S; Proost P
Clin Exp Allergy; 2018 Oct; 48(10):1333-1344. PubMed ID: 29978510
[TBL] [Abstract][Full Text] [Related]
6. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
Watterson D; Kobe B; Young PR
J Gen Virol; 2012 Jan; 93(Pt 1):72-82. PubMed ID: 21957126
[TBL] [Abstract][Full Text] [Related]
7. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
Tiwari V; Liu J; Valyi-Nagy T; Shukla D
J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
[TBL] [Abstract][Full Text] [Related]
8. Novel antiviral activity of chemokines.
Nakayama T; Shirane J; Hieshima K; Shibano M; Watanabe M; Jin Z; Nagakubo D; Saito T; Shimomura Y; Yoshie O
Virology; 2006 Jul; 350(2):484-92. PubMed ID: 16603217
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
10. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.
Rueda P; Balabanian K; Lagane B; Staropoli I; Chow K; Levoye A; Laguri C; Sadir R; Delaunay T; Izquierdo E; Pablos JL; Lendinez E; Caruz A; Franco D; Baleux F; Lortat-Jacob H; Arenzana-Seisdedos F
PLoS One; 2008 Jul; 3(7):e2543. PubMed ID: 18648536
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.
Hallak LK; Spillmann D; Collins PL; Peeples ME
J Virol; 2000 Nov; 74(22):10508-13. PubMed ID: 11044095
[TBL] [Abstract][Full Text] [Related]
13. Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.
Crim RL; Audet SA; Feldman SA; Mostowski HS; Beeler JA
J Virol; 2007 Jan; 81(1):261-71. PubMed ID: 17050595
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
Budge PJ; Graham BS
J Antimicrob Chemother; 2004 Aug; 54(2):299-302. PubMed ID: 15254023
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.
Techaarpornkul S; Collins PL; Peeples ME
Virology; 2002 Mar; 294(2):296-304. PubMed ID: 12009871
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
18. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
Budge PJ; Li Y; Beeler JA; Graham BS
J Virol; 2004 May; 78(10):5015-22. PubMed ID: 15113882
[TBL] [Abstract][Full Text] [Related]
19. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
[TBL] [Abstract][Full Text] [Related]
20. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
